Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Association between medication therapy management eligibility and adherence among us renal transplant recipients

  • At: 2016 FIP Congress in Buenos Aires (Argentina)
  • Type: Poster
  • By: SPIVEY, Christina (University Of Tennessee Health Science Center, Clinical Pharmacy, Memphis, United States)
  • Co-author(s): Christina Alease Spivey:Clinical Pharmacy,University Of Tennessee Health Science Center,Memphis,United States|Marie Chisholm-Burns:Clinical Pharmacy,University Of Tennessee Health Science Center,Memphis,United States|Elizabeth Tolley:Preventive Medicine,University Of Tennessee Health Science Center,Memphis,United States|Erin Kaplan:Preventive Medicine,University Of Tennessee Health Science Center,Memphis,United States
  • Abstract:

    Medication therapy management (MTM) is a benefit of Medicare Part D available to beneficiaries who meet criteria established by the Centers for Medicare and Medicaid Services (CMS). No published studies have examined the impact of Part D MTM eligibility on renal transplant recipients’ (RTRs) immunosuppressant therapy (IST) adherence.

    Cross-sectional

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses